Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)
- Status
- UNKNOWN
- Phase
- PHASE3
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
- Status
- SUSPENDED
- Phase
- PHASE4
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
- Status
- COMPLETED
- Phase
- NA
Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects
- Status
- COMPLETED
- Phase
- PHASE2
COVID-19 in Patients With HIV
- Status
- COMPLETED
- Phase
- N/A
Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy
- Status
- COMPLETED
- Phase
- N/A
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
- Status
- TERMINATED
- Phase
- PHASE3
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary
- Status
- TERMINATED
- Phase
- NA
COVID-19 Pandemic Response Network
- Status
- COMPLETED
- Phase
- N/A
Prognostic Factors of Patients With COVID-19
- Status
- COMPLETED
- Phase
- N/A
A Trial of Remdesivir in Adults With Severe COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
- Status
- SUSPENDED
- Phase
- PHASE3